TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|162|2|210-220

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.162, Iss.2, 2013-07, pp. : 210-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome Inhibition: Novel Therapy for Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 162-168

Karger

Access to resources Recommend Favorite

Andrographolide derivative AL‐1 improves insulin resistance through down‐regulation of NF‐κB signalling pathway

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 12, 2015-06 ,pp. : 3151-3158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 2, 2012-01 ,pp. : 337-343

Spandidos Publications

Access to resources Recommend Favorite

Anti‐tumour activity of interferon‐alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 251-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Per a 10 protease activity modulates CD40 expression on dendritic cell surface by nuclear factor‐kappaB pathway

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 2, 2015-05 ,pp. : 341-351

John Wiley & Sons Inc

Access to resources Recommend Favorite